{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:54:06Z","timestamp":1760784846523,"version":"3.41.2"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":117,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Research and Development (Social Development) Program of Jiangsu Province","award":["BL2012037"],"award-info":[{"award-number":["BL2012037"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. We aim at investigating the correlation between skip N2 metastases (SN2) and SUV<jats:sub>max<\/jats:sub>, long diameter of tumor mass after <jats:sup>18<\/jats:sup>F\u2010FDG PET\/CT, and pathological Ki67 expression in patients with non\u2010small\u2010cell lung cancer (NSCLC). <jats:italic>Methods and Results<\/jats:italic>. We retrospectively analyzed the factors that might affect the pathogenesis of SN2 in these patients. The clinical SN2 symptoms in patients with squamous carcinoma or adenocarcinoma were investigated. The work curve was utilized to analyze the optimal cutoff value for the SUV<jats:sub>max<\/jats:sub> and long diameter of tumor. Multivariate analysis revealed that high expression of Ki67 was a risk factor for mediastinal SN2 (OR = 1.042, 95% CI: 1.009\u20101.076). Subgroup analysis indicated that the SUV<jats:sub>max<\/jats:sub> of the non\u2010SN2 group was significantly higher than that of the SN2 group in patients with squamous carcinoma (16.3 \u00b1 6.0 vs. 10.7 \u00b1 5.6, <jats:italic>P<\/jats:italic> = 0.026). In the patients with adenocarcinoma, the long diameter of tumor in the SN2 group was significantly longer than that of the non\u2010SN2 group (43.8 \u00b1 16.3\u2009mm vs. 30.1 \u00b1 13.8\u2009mm, <jats:italic>P<\/jats:italic> = 0.032). The Ki67 expression in the SN2 group was significantly higher than that of the non\u2010SN2 group (51.7 \u00b1 24.0 vs. 30.0 \u00b1 19.2, <jats:italic>P<\/jats:italic> = 0.028). <jats:italic>Conclusions<\/jats:italic>. The differences of clinical features of the patients in the SN2 group and non\u2010SN2 group in the NSCLC patients were associated with the pathological subtypes, which were featured by lower SUV<jats:sub>max<\/jats:sub> in the SN2 of the squamous carcinoma, and longer diameter of SN2 in the adenocarcinoma patients.<\/jats:p>","DOI":"10.1155\/2020\/9298358","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:37:14Z","timestamp":1588030634000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between Skip N2 Metastases and SUV<sub>max<\/sub>, Long Diameter of Tumor, and Ki67 Expression in Patients with Non\u2010Small\u2010Cell Lung Cancer"],"prefix":"10.1155","volume":"2020","author":[{"given":"Wang","family":"Jian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Ming-ya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Long-bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-3394","authenticated-orcid":false,"given":"Zhao","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-6933","authenticated-orcid":false,"given":"Shao","family":"Guo-qiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37132015000004479"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.06.081"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy142"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.011"},{"key":"e_1_2_8_6_2","first-page":"267","article-title":"18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study","volume":"46","author":"Higashi K.","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs604"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.4.1132"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.12808"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009519.pub2"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu244"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.12.007"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.01.176"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2004.01.025"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rx.2016.12.001"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9257929"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4218-0"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1524-2"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-017-0608-5"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990100602"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24702"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2020\/9298358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2020\/9298358.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2020\/9298358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T06:24:09Z","timestamp":1735626249000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2020\/9298358"}},"subtitle":[],"editor":[{"given":"Kumud K.","family":"Kafle","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1155\/2020\/9298358"],"URL":"https:\/\/doi.org\/10.1155\/2020\/9298358","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"type":"print","value":"2314-6133"},{"type":"electronic","value":"2314-6141"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2019-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"9298358"}}